A Study to Evaluate the Efficacy and Safety of CBL-514 Compared to Placebo in Participants With Dercum's Disease Lipomas
Clinical trial NCT06303570 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06303570
- Sponsor
- Caliway Biopharmaceuticals Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-27
- Primary completion
- 2026-03-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.